Cutler Group LP Synlogic, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$2.27 - $3.0 $1,816 - $2,400	-800 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$3.0 - $4.39 $1,500 - $2,195	-500 Reduced 38.46%	800 $3,000
Q1 2021 Apr 26, 2021	BUY	$2.2 - $5.05 $880 - $2,020	400 Added 44.44%	1,300 $4,000
Q4 2020 Jan 21, 2021	BUY	$1.85 - $2.54 $925 - $1,270	500 Added 125.0%	900 $1,000
Q1 2020 May 07, 2020	BUY	$1.39 - $3.19 $556 - $1,276	400 New	400 $0
Q4 2019 Feb 06, 2020	SELL	$1.96 - $2.81 $196 - $281	-100 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$2.12 - $9.37 $212 - $936	100 New	100 $0

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.